Plasma Levels of Matrix Metalloproteinase (MMP)-2, MMP-9 and Tumor Necrosis Factor-α in Chronic Hepatitis C Virus Patients
Open Access
- 31 August 2015
- journal article
- Published by Bentham Science Publishers Ltd. in The Open Microbiology Journal
- Vol. 9 (1) , 136-140
Abstract
Background: In chronic HCV infection, pathological accumulation of the extracellular matrix is the main feature of liver fibrosis; that indicates the imbalanced rate of increased matrix synthesis to decreased breakdown of connective tissue proteins. Matrix metalloproteinases (MMPs) play a crucial role in remodeling of extracellular matrix. It is known that expression of MMPs is regulated by Tumor necrosis factor (TNF)-α. Also, levels of TNF-α in liver and serum are increased in chronic HCV patient. Accordingly, this study aimed to correlate the plasma levels of MMP-2, MMP-9 and TNF-α in chronic HCV patients with the pathogenesis of the liver. Methods: The current study was conducted on 15 fibrotic liver cases with detectable HCV RNA, 10 HCV cirrhotic liver cases, and 15 control subjects of matched age and sex. Plasma MMP-2, MMP-9 and TNF-α were measured by ELISA. Results: Data revealed that the MMP2, MMP9 and TNF-α levels showed a significant elevation in chronic HCV patients compared to control group (p= 0.001). But, no significant correlation was observed in levels of MMP-2, MMP-9, and TNF-α between fibrotic and cirrhotic cases. Conclusions: MMP-2, MMP-9 and TNF-α showed high reproducibility to differentiate chronic HCV patients from control group. On the contrary, MMP-2, MMP-9 and TNF-α were not able to differentiate fibrotic from cirrhotic liver cases. Thus, MMP-2, MMP-9 and TNF-α could not be correlated with the progression of liver disease. Rather they could be used as prognostic markers of liver fibrosis.Keywords
This publication has 24 references indexed in Scilit:
- Dendritic cells, regulatory T cells and the pathogenesis of chronic hepatitis CVirulence, 2012
- Mechanisms for Insulin Resistance: Common Threads and Missing LinksCell, 2012
- Twelve potential fibrosis markers to differentiate mild liver fibrosis from cirrhosis in patients infected with chronic hepatitis C genotype 1European Journal of Clinical Microbiology & Infectious Diseases, 2011
- Significance of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in chronic hepatitis C patientsActa Microbiologica Et Immunologica Hungarica, 2010
- Determination of Hepatitis C Virus–Infected, Monocyte Lineage Reservoirs in Individuals With or Without HIV CoinfectionThe Journal of Infectious Diseases, 2009
- Viral and Host Factors Induce Macrophage Activation and Loss of Toll-Like Receptor Tolerance in Chronic HCV InfectionGastroenterology, 2007
- Liver fibrosis – from bench to bedsideJournal of Hepatology, 2003
- Increased Extracellular Matrix Remodeling Is Associated With Tumor Progression in Human Hepatocellular CarcinomasHepatology, 2001
- Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinomaHepatology, 1996
- Tumor necrosis factor α gene expression and the response to interferon in chronic hepatitis CHepatology, 1996